Lupiflex 8 Tablet is a combination medication containing Ketoprofen 100 mg and Thiocolchicoside 8 mg, formulated for the management of musculoskeletal pain and associated inflammatory conditions. Ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain, inflammation, and fever. Thiocolchicoside, a muscle relaxant with anti-inflammatory properties, acts as a selective antagonist of GABA and glycine receptors in the spinal cord, leading to muscle relaxation and relief from muscle spasms. The combination of these two active ingredients provides effective symptomatic relief in conditions such as acute musculoskeletal disorders, low back pain, muscle spasms, and painful inflammatory states. Lupiflex 8 is indicated for short-term use under medical supervision due to potential side effects associated with NSAIDs, including gastrointestinal irritation, cardiovascular risks, and renal impairment. Thiocolchicoside may cause drowsiness or dizziness; therefore, caution is advised when performing tasks requiring alertness. Contraindications include hypersensitivity to either component, peptic ulcer disease, severe hepatic or renal impairment, and pregnancy. Dosage and duration should be individualized based on clinical response and tolerability. Regular monitoring is recommended during prolonged therapy to minimize adverse effects.